View Clinical Trial (Medical Research Study)
Detoxification and Treatment of Subjects With Medication Overuse Headache - NCT00432549-06902(Clinical Trial 162123)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Stamford |
|
State:
|
|
CT |
| Zip Code: |
|
06902 |
| Conditions: |
|
Analgesic Rebound Headache |
| Purpose: |
|
The purpose of this study is to assess the benefits of almotriptan used as a transitional
therapy and topiramate in subjects with medication overuse headaches (MOH.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Medication overuse headaches 18 years of age and older Must have a diagnosis of
probable medication overuse headache Must have greater than fifteen headache days per
month Must be in generally good health Female subjects must be postmenopausal or
practicing an acceptable method of birth control
Exclusion Criteria:
- Not overusing six or more tablets per day of compounds containing barbituates opioids
No overuse of triptans Previous failure or side effects with topiramate or
almotriptan Cannot be pregnant or lactating |
|
|
|
| Study is available at: |
|
The New England Center for Headache, P.C.
Stamford, CT 06902
United States
Primary Contact:
Alfredo DaSilva
Email: adasilva@nech.net
Phone: 203-322-2748 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|